ZA855407B - Neuromuscular blocking compounds - Google Patents

Neuromuscular blocking compounds

Info

Publication number
ZA855407B
ZA855407B ZA855407A ZA855407A ZA855407B ZA 855407 B ZA855407 B ZA 855407B ZA 855407 A ZA855407 A ZA 855407A ZA 855407 A ZA855407 A ZA 855407A ZA 855407 B ZA855407 B ZA 855407B
Authority
ZA
South Africa
Prior art keywords
neuromuscular blocking
blocking compounds
image
neuromuscular
anion
Prior art date
Application number
ZA855407A
Other languages
English (en)
Inventor
Roy Archibald Swaringer Jr
Hassan Ali El-Sayad
David Arthur Yoewell
John Joseph Savarese
Original Assignee
Wellcome Found
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found, Gen Hospital Corp filed Critical Wellcome Found
Publication of ZA855407B publication Critical patent/ZA855407B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Jib Cranes (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Fats And Perfumes (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Cephalosporin Compounds (AREA)
ZA855407A 1984-07-18 1985-07-17 Neuromuscular blocking compounds ZA855407B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848418303A GB8418303D0 (en) 1984-07-18 1984-07-18 Compounds

Publications (1)

Publication Number Publication Date
ZA855407B true ZA855407B (en) 1986-04-30

Family

ID=10564058

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA855407A ZA855407B (en) 1984-07-18 1985-07-17 Neuromuscular blocking compounds

Country Status (30)

Country Link
US (1) US4761418A (fr)
EP (1) EP0181055B1 (fr)
JP (1) JPH0662568B2 (fr)
AT (1) ATE60759T1 (fr)
AU (1) AU574481B2 (fr)
BG (1) BG60411B2 (fr)
CA (1) CA1273341A (fr)
CY (1) CY1687A (fr)
DD (1) DD235638A5 (fr)
DE (2) DE3581699D1 (fr)
DK (1) DK168093B1 (fr)
ES (1) ES8609260A1 (fr)
FI (1) FI85019C (fr)
GB (1) GB8418303D0 (fr)
GE (1) GEP19960468B (fr)
HK (1) HK47593A (fr)
HU (1) HU193996B (fr)
IE (1) IE58138B1 (fr)
IL (1) IL75833A (fr)
LT (1) LT2078B (fr)
LU (1) LU88801I2 (fr)
LV (1) LV5483A3 (fr)
MC (1) MC1690A1 (fr)
MX (1) MX9203667A (fr)
NL (1) NL940023I2 (fr)
NZ (1) NZ212766A (fr)
PL (1) PL146066B1 (fr)
SG (1) SG3493G (fr)
SU (1) SU1468414A3 (fr)
ZA (1) ZA855407B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453510A (en) * 1990-07-13 1995-09-26 Burroughs Wellcome Co. Neuromuscular blocking agents
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
US5510355A (en) * 1994-09-06 1996-04-23 Bencherif; Merouane Depolarizing skeletal muscle relaxants
ATE295351T1 (de) * 1997-03-25 2005-05-15 Avera Pharmaceuticals Inc Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker
GB0204087D0 (en) * 2002-02-21 2002-04-10 Legislator 1563 Ltd Di-ester derivatives as short acting neuromuscular blockers
US20050192243A1 (en) * 2003-10-28 2005-09-01 Savarese John J. Neuromuscular blocking agents and antagonists thereof
US7872137B2 (en) * 2006-06-20 2011-01-18 Farmabios S.P.A. Process for the preparation of mivacurium chloride
AU2007328210B2 (en) * 2006-12-06 2012-11-22 Cornell Research Foundation, Inc. Intermediate duration neuromuscular blocking agents and antagonists thereof
AU2008222298A1 (en) * 2007-03-08 2008-09-12 Chemagis Ltd. (1R,1'R)-atracurium salts separation process
BRPI0808581A2 (pt) * 2007-03-26 2014-09-16 Chemagis Ltd "método para separar cisatracúrio com alta pureza de uma mistura de isômeros de (1r, 1'r) - atracúrio"
WO2008132746A1 (fr) * 2007-05-01 2008-11-06 Chemagis Ltd. Nouveaux composés d'isoquinolinium utiles dans la préparation de cisatracurium et intermédiaires associés
WO2009007946A1 (fr) * 2007-07-09 2009-01-15 Chemagis Ltd. Procédé de fabrication de cisatracurium et d'intermédiaires associés
EP2155684B1 (fr) * 2007-05-01 2014-04-09 Chemagis Ltd. Procédé de fabrication de composés de cisatracurium et intermédiaires associés
CA2687157A1 (fr) * 2007-06-18 2008-12-24 Chemagis Ltd. Procede de separation de sels de (1r,1'r)-atracurium
AU2008320380A1 (en) * 2007-10-29 2009-05-07 Chemagis Ltd. Novel R,R'-atracurium salts
ITMI20080319A1 (it) 2008-02-28 2009-08-29 Recordati Chem Pharm Processo per la risoluzione di derivati isochinolinici
AU2009241211A1 (en) * 2008-05-01 2009-11-05 Chemagis Ltd. Cisatracurium derivatives, preparation and uses thereof
WO2010107488A1 (fr) 2009-03-17 2010-09-23 Cornell University Agents de blocage neuromusculaires non dépolarisants réversibles et leur méthode
WO2011022491A1 (fr) 2009-08-19 2011-02-24 Cornell University Cystéine pour injection physiologique
WO2013021398A2 (fr) * 2011-08-05 2013-02-14 Sequent Scientific Limited Procédé de préparation du chlorure de mivacurium
ES2625329T3 (es) 2012-06-29 2017-07-19 Cornell University Agentes bloqueantes neuromusculares asimétricos reversibles de duración ultra-corta, corta o intermedia
CN103373959A (zh) * 2013-06-14 2013-10-30 安徽省先锋制药有限公司 顺式苄基异喹啉类化合物的制备方法及其用途
CN107778237A (zh) * 2016-08-26 2018-03-09 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂中间体的新晶型及其制备方法和用途
CN107782821B (zh) * 2016-08-26 2021-11-09 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂的分析方法
CN108938573B (zh) * 2017-05-26 2021-08-10 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂组合物及其制备方法和用途
CN108503564A (zh) * 2017-09-30 2018-09-07 武汉嘉诺康医药技术有限公司 一种米库氯铵中间体及利用该中间体合成米库氯铵的方法
CN110361472B (zh) * 2019-07-29 2022-04-29 武汉嘉诺康医药技术有限公司 一种米库氯铵中间体miv-g异构体的hplc检测方法
CN111004179B (zh) * 2019-11-11 2021-03-09 武汉大安制药有限公司 一种5’-甲氧基劳丹素的拆分方法
CN116410078A (zh) * 2021-12-29 2023-07-11 苏州特瑞药业股份有限公司 一种制备(e)-辛-4-烯-1,8-二酸的方法
WO2025140288A1 (fr) * 2023-12-25 2025-07-03 上海森辉医药有限公司 Tétrahydroisoquinoléine et son utilisation pharmaceutique

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB863717A (en) * 1958-07-03 1961-03-22 Allen & Hanburys Ltd Tetrahydropapaverine derivatives and their preparation
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
US4192877A (en) * 1977-08-01 1980-03-11 Massachusetts General Hospital Neuromuscular blocking agents
AU523706B2 (en) * 1977-08-01 1982-08-12 The Massachusetts General Hospital Neuromuscular blocking agents
CA1125287A (fr) * 1978-07-21 1982-06-08 John J. Savarese Modes d'emploi de substances a base de bis-isoquinolinium
US4235906A (en) * 1978-07-21 1980-11-25 Massachusetts General Hospital Bis-isoquinolinium compounds, compositions and methods of use
US4491665A (en) * 1979-10-19 1985-01-01 Burroughs Wellcome Co. Method of preparing isomers of bis isoquinolinium compounds
CA1153380A (fr) * 1979-10-19 1983-09-06 Hassan A. El-Sayad Sels de tetrahydroisoquinolinium, agents de blocage neuromusculaire
EP0054309B1 (fr) * 1980-12-17 1984-08-22 The Wellcome Foundation Limited Bloqueurs neuromusculaires à action prolongée, compositions pharmaceutiques les contenant et leurs procédés de préparation
JPS5899465A (ja) * 1981-11-23 1983-06-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド イソキノリン誘導体

Also Published As

Publication number Publication date
MC1690A1 (fr) 1986-07-18
PL254571A1 (en) 1986-07-15
ATE60759T1 (de) 1991-02-15
FI852807L (fi) 1986-01-19
SG3493G (en) 1993-03-12
CA1273341A (fr) 1990-08-28
NZ212766A (en) 1988-03-30
SU1468414A3 (ru) 1989-03-23
IE851791L (en) 1986-01-18
JPS6187666A (ja) 1986-05-06
LV5483A3 (lv) 1994-03-10
ES545319A0 (es) 1986-09-01
IL75833A (en) 1988-11-30
FI852807A0 (fi) 1985-07-17
LU88801I2 (fr) 1996-11-05
GB8418303D0 (en) 1984-08-22
NL940023I2 (nl) 1998-06-02
US4761418A (en) 1988-08-02
DK324985A (da) 1986-01-19
IE58138B1 (en) 1993-07-14
AU4510885A (en) 1986-01-23
FI85019C (fi) 1992-02-25
DK324985D0 (da) 1985-07-17
MX9203667A (es) 1992-07-31
PL146066B1 (en) 1988-12-31
DD235638A5 (de) 1986-05-14
EP0181055A1 (fr) 1986-05-14
AU574481B2 (en) 1988-07-07
HK47593A (en) 1993-05-21
LT2078B (lt) 1993-06-15
DK168093B1 (da) 1994-02-07
EP0181055B1 (fr) 1991-02-06
NL940023I1 (nl) 1995-01-02
DE3581699D1 (de) 1991-03-14
ES8609260A1 (es) 1986-09-01
IL75833A0 (en) 1985-11-29
GEP19960468B (en) 1996-08-29
BG60411B2 (bg) 1995-02-28
HU193996B (en) 1987-12-28
JPH0662568B2 (ja) 1994-08-17
HUT40626A (en) 1987-01-28
DE19675039I2 (de) 2003-01-09
FI85019B (fi) 1991-11-15
CY1687A (en) 1993-10-10

Similar Documents

Publication Publication Date Title
ZA855407B (en) Neuromuscular blocking compounds
ZA857270B (en) Tetralin derivatives,their preparation and their use
DE3378470D1 (en) 7-oxabicycloheptane substituted amino prostaglandin analogs
ZA895090B (en) Novel benzopyran derivatives,processes for their preparation and their use and preparations containing the compounds
DE3562238D1 (en) Substituted sulfonamidobenzamides, antiarrythmic agents and compositions thereof
IL72354A0 (en) Imidazolium salts,processes for the preparation thereof and pharmaceutical compositions containing the same
HU906007D0 (en) Process for the preparation of pyrimidine-4,6-dicarbonic acid-diamides and medical preparations containing them as active agents
DE3173954D1 (en) Use of adenosin derivatives for the manufacture of psychopharmacons
AR242561A1 (es) Procedimiento para la preparacion de clorhidrato de s-(-)-1-propil-2',6'-pipecoloxilidida opticamente sustancialmente puro y procedimiento
GR861169B (en) Method for preparing n-(quinolyl) glycinamide derivatives and their application as psychotropes
ZA879280B (en) Basically substituted phenylacetonitriles,their preparation and drugs containing these compounds
NZ217418A (en) Tricyclic heterocyclic compounds and pharmaceutical compositions
DE2966809D1 (en) 3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them
ZA904524B (en) Dibenzo(1,5)dioxocin-5-one derivatives,their use in medicaments and processes for their preparation
EP0207606A3 (fr) Utilisation de la pinacidil comme médicament anti-asthmatique
EP0418990A3 (en) 13-bromo and 13,14-dibromo ergoline, their preparation and their use
AU3881889A (en) Human interferon-gamma, process to prepare said human interferon-gamma, and its use
DE3173866D1 (en) Compounds and compositions for treatment of ocular hypertension
ES2027507A6 (es) Procedimiento de preparacion de derivados selenofenicos.
YU134489A (en) Process for preparing vapours of enanthiomers (ar,1's)(as,1'r)-3-/n-(metoxyacethyl)-n-(3-chlorine-2,6-diethylphenyl)/-amino-tetrahydro-2-furanone